Rising Biosciences Inc (RBII) 股利

Rising Biosciences, Inc. engages in the research and development of alternative patient care treatments. The company is headquartered in Tustin, California. The company went IPO on 2001-06-21. The firm is focused on oral and topical cannabis and non-cannabis-based pharmaceuticals. The firm operates through three distinct business units. In addition to Oxi Thyme, the second business unit is a physician’s practice management company focused on the proper use of cannabis for the treatment of chronic pain, opioid addiction, and terminal patients. The third business unit is a research and development company focused on oral and topical pharmaceuticals. Through its subsidiaries and investment holdings, the Company is focused on the treatment of individuals in both inpatient and outpatient environments recovering from alcohol and drug addiction.